JR..I disagree that Pfizer is out of the running...Haleon, a non- prescription drug company is 32% owned by Pfizer and they have announced plans to sell their stake in the company...This will provide them with several times the amount of cash they need to buy Amarin without the need for borrowing to make the deal.
News 
Market Data 
Discover 
AI
